See also this year's filing and all EDGAR filings for this company.
PDF Report 0001501989_2023_CytomX_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001501989, CytomX Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 237,102,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 949,000 |
| 2 | PropertyPlantAndEquipmentNet | 5,072,000 |
| 3 | remainder_Assets | 17,768,000 |
| 4 | LiabilitiesCurrent | 152,608,000 |
| 5 | LiabilitiesNoncurrent | 194,034,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 42,849,000 |
| 9 | ResearchAndDevelopmentExpense | 111,649,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 53,163,000 |
| 12 | remainder_NetIncome | 2,018,000 |
| 13 | remainder_ComprehensiveNetIncome | 252,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 260,891,000 |
| 1 | Liabilities | 346,642,000 |
| 2 | Expenses | 154,498,000 |
| 3 | Revenues | 53,163,000 |
| 4 | StockholdersEquity | -85,751,000 |
| 5 | NetIncome | -99,317,000 |
| 6 | ComprehensiveNetIncome | -99,191,000 |
| 7 | BaseVar | 408,732,000 |
| 8 | EconomicCapitalRatio | -0.812 |